Axon Therapies
Rebalancing heart failure with SAVM
United States · $32.0M raised
- Business Model
- B2B
- Website
- axontherapies.com
- Total Funding
- $32.0M
- Last Round
- Series ASep 2025
- Rounds
- 1
About
Medical device company developing splanchnic nerve ablation therapy to treat heart failure by rebalancing the autonomic nervous system.
Summary
Axon Therapies is a Biotech company based in United States. It has raised $32.0M in total across 1 round, most recently a Series A round in Sep 2025. Investors include Earlybird Venture Capital, Sante Ventures and Deerfield Management.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2025
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...